Compare Agilent Technologies Inc (A) vs The Coca-Cola Co K (KO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Agilent Technologies Inc vs The Coca-Cola Co K — how do they compare? Agilent Technologies Inc trades at $149.35 (market cap $42.00B), while The Coca-Cola Co K trades at $86.57 (market cap $373.76B). The key difference: The Coca-Cola Co K is far larger — about 8.9× Agilent Technologies Inc's market cap, and The Coca-Cola Co K pays the higher dividend (2.44%). Which is the better fit depends on your goals.
| A | KO | |
|---|---|---|
Market Cap | $42.00B | $373.76B |
Sector | Health | Consumer Staples |
52-Week High | $157.20 | $89.08 |
52-Week Low | $110.24 | $65.67 |
Enterprise Value | $43.55B | $400.93B |
Dividend Yield | 0.69% | 2.44% |
Volume | — | 14,630,257 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $145.97, up 3.28% in the last session, with a bullish technical outlook from moving averages but overbought RSI levels. The company reported strong Q1 2026 earnings, beating estimates with EPS of $1.49, and maintains solid profitability with a net income margin of 19.55%. Recent developments include FDA and EU approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its healthcare portfolio.
The stock offers upside to the consensus price target of $154.90, supported by analyst optimism (77.5% buy ratings), but high valuation ratios like a P/E of 146.56 pose risks. Investors should monitor execution of growth initiatives and competitive pressures in the life sciences sector, with earnings on August 26, 2026, as a key catalyst.
Coca-Cola (KO) trades at $86.48, down 0.65% on the day. The stock shows strong fundamentals with a 27.33% net income margin in 2025 and consistent earnings beats in recent quarters. Technical indicators are bullish, with the price above key support levels. Recent news highlights institutional buying and stable demand trends, while the company maintains a 64-year dividend growth streak.
Outlook is positive with a consensus price target of $95.83, implying 11% upside. Risks include regional demand volatility and high debt levels. The stock offers a reliable dividend but faces margin pressure from inflation and competition.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About The Coca-Cola Co K
The Coca-Cola Company manufactures, markets, and distributes soft drink concentrates and syrups. The Company also distributes and markets juice and juice-drink products. Coca-Cola distributes its products to retailers and wholesalers in the United States and internationally.
Read more on KO →
